每经AI快讯，有投资者在投资者互动平台提问：公司的研发实力很强，浙江又是莹石的主要产区，请 问新和成有无氟化工产品或项目储备？在化工行业将来会有全球首发的材料吗？ 新和成（002001.SZ）2月11日在投资者互动平台表示，公司目前氟化工相关产品主要为全氟己基辛烷、 全氟丁基戊烷。 （文章来源：每日经济新闻） ...

Group 1 - The core point of the article is that Xinhecheng's perfluorohexyl octane product is currently being sold normally, primarily for use in the pharmaceutical sector [2] Group 2 - The product's application in the pharmaceutical field indicates a potential growth area for the company [2] - The announcement was made on an interactive platform, highlighting the company's engagement with stakeholders [2]

Group 1 - The core product of the company, perfluorohexyl octane, is an important raw material for drugs treating dry eye syndrome [2] - The company responded to an investor inquiry regarding the application of its product in innovative pharmaceuticals [2] - The interaction took place on an investor communication platform, indicating active engagement with stakeholders [2]

Group 1 - The company, Xinhecheng, has achieved its designed production capacity of 45 tons of perfluorohexyl octane annually and is capable of supplying based on customer demand [2]

Group 1 - The company announced on November 24 that it has achieved production capacity for two key products: 45 tons of perfluorohexyl octane and 15 tons of perfluorobutyl pentane [2] - These products are important raw materials for drugs treating dry eye syndrome and have obtained drug registration [2]

Group 1: Company Overview - The company is Zhejiang Xinhacheng Co., Ltd., with stock code 002001 and abbreviation Xinhacheng [1] - The investor relations activity was recorded under number 2025-014 [1] Group 2: Investor Relations Activity - The activity included a strategy meeting with various investment firms and analysts [2] - Key participants included representatives from Guosen Securities, Qianhai Hezhi, and Huaxia Fund among others [2] Group 3: Project Updates - The Tianjin Nylon New Materials project commenced pile foundation construction in September 2025 and is expected to be completed by 2027 [3] - The company has a solid methionine production capacity of 30,000 tons, with an expansion project of 70,000 tons nearing completion [3] - The Heilongjiang base focuses on bio-fermentation products, including Vitamin C and various amino acids, enhancing overall efficiency through technological upgrades [3] Group 4: New Materials and Product Development - The company aims to be a leader in the new materials sector, focusing on high-performance polymers like PPS, with a current capacity of 22,000 tons and plans for expansion [4] - The fragrance segment produces various products, including linalool and citral, with ongoing projects to enhance product offerings [4] Group 5: Future Plans and Strategic Focus - The company plans to focus on health and high polymer new materials, emphasizing integrated and collaborative development strategies [6] - A share buyback plan is in place, with a total amount of 300 million to 600 million yuan allocated for stock repurchase to enhance investor confidence [6]

Group 1 - The company has established production capabilities for perfluorohexane and perfluorobutylpentane, with an annual output of 45 tons and 15 tons respectively [2] - Both products are important raw materials for the treatment of dry eye disease and have obtained drug registration [2] - The company is responding to investor inquiries regarding the market potential and exclusivity of these products [2]